GHTF Takes Prospective Approach To Address Innovative Medical Technology
This article was originally published in The Silver Sheet
Executive Summary
GHTF PLAN FOR NEW AND EMERGING MEDICAL TECHNOLOGY seeks to create a mechanism for developing a harmonized regulatory approach for dealing with innovative products to avoid the proliferation of country-specific guidelines. During the ninth Global Harmonization Task Force meeting in Singapore, the GHTF Steering Committee outlined a proposed plan for taking a prospective approach to emerging technology – part of a series of "strategic goals" designed to guide the direction of the task force over the next few years. Participants and at the conference discussed at length the extensive challenges for regulators and industry posed by the coming flood of new medical technology and warned that without immediate action, innovation could be stifled
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.